Oxygen diffusive wound dressings and methods of manufacturing and use are described herein. The wound dressing may generally provide a ready supply of oxygen to a wound being treated via one or more oxygen conduits which are designed to pass oxygen from ambient air or other oxygen reservoirs into proximity to the wound, and may also provide for exudate removal through transecting channels in fluid communication with both the wound surface and a hydrophilic absorbent material.

A system for treating a tissue site of a patient includes a dressing filler adapted to be positioned at the tissue site. The dressing filler includes a porous substrate having at least one compressed region and at least one expanded region. The compressed region of the porous substrate is held in a compressed state by a first coating capable of dissolving in the presence of a fluid, and the expanded region of the porous substrate is held in an expanded state by a second coating.

A cranial cap dressing for dressing a craniotomy wound comprising a breathable elastic outer layer sized to fit snuggly on a human head of a patient and an absorbent inner layer attached to the breathable elastic outer layer.

The wound dressing described herein includes a backing layer, absorbent layer, and foam layer. The wound dressing also includes one or more visual indicators. The visual indicators are substantially non-visible in their initial, dehydrated state. As the visual indicators absorb fluid they swell and become visible. The visual indicators enable a caregiver to know when the wound dressing has reached, or is about to reach, its fluid capacity.

A wound care device for debriding a wound, said device is in the form of a foam pad with two layers of different foams. At one surface of the device is provided a pattern of grooved at the central portion. The grooves improve the ability of removing and collecting debris from a wound during cleaning of such.

A dressing consists substantially of a hydrophilic membrane layer, a superabsorbent material positioned on the hydrophilic membrane layer, and a film layer coupled to the hydrophilic membrane layer and configured to confine the superabsorbent material between the film layer and the hydrophilic membrane layer. The film layer has a high moisture vapor transfer rate.

A medical bandage is provided, capable of being rapidly, adjustably, intuitively and universally fitted on a head, limb, stump, finger or other body part, such as to conceal and protect a wound. The medical bandage is cap-shaped and deformable, is formed of several layers, and comprises at least one port for obtaining quick access to a wound concealed by the medical bandage. When open, a port can stabilize a drainage tube, or provide a passage through which to easily and rapidly apply a medicine. The medical bandage can be directly fit on the head or other body part, providing an all-in-one dressing, wrap and treatment, and eliminating the need for cumbersome and difficult to manage gauze roll and multiple bandages of various sizes, shapes, and uses. The medical bandage can include one or more sensors for measuring or monitoring body parameters or functions.

A super-absorbent dressing assembly for use with a reduced-pressure wound treatment system includes a breathable, fluid restricted dry layer for placement against a wound, a super-absorbent layer, and a non-breathable layer, and a drape extending over the non-breathable layer. A reduced-pressure interface is available to fluidly couple the super-absorbent layer to a reduced-pressure subsystem. The super-absorbent dressing assembly preferably supplies a compressive force when placed under reduced pressure. A reduced-pressure treatment system uses a super-absorbent bolster to treat wounds, e.g., linear wounds.

The present invention relates to a composition that can be used as or as part of a wound dressing and to wound dressings comprising the same. More specifically, the present invention relates to a composition that disrupts and kills bacteria within a biofilm and also prevents biofilm formation. The composition comprises a first component selected from the group consisting of chitosan, chitin, derivatives of chitosan, derivatives of chitin, and combinations thereof; at least one triprotic acid and at least one solubilising acid.

Wound pads and systems and kits comprising wound pads whose total thickness can be modified by a user without the use of tools, comprising a plurality of separable layers having layer thicknesses less than the thickness of the wound pad. The wound pads may be used as wound fillers in the context of negative pressure wound therapy (also known as vacuum treatment, reduced pressure treatment).